Rankings
▼
Calendar
PRAX Q1 2023 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena
PRAX
Praxis Precision Medicines, Inc.
$7B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$683,000
Gross Profit
-$25M
-3634.1% margin
Operating Income
-$38M
-5577.0% margin
Net Income
-$37M
-5483.9% margin
EPS (Diluted)
$-10.58
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$33M
Free Cash Flow
-$33M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$98M
Total Liabilities
$34M
Stockholders' Equity
$64M
Cash & Equivalents
$81M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$683,000
$0
—
Gross Profit
-$25M
-$53M
+52.9%
Operating Income
-$38M
-$69M
+44.7%
Net Income
-$37M
-$69M
+45.5%
Revenue Segments
License
$700,000
100%
← FY 2023
All Quarters
Q2 2023 →